Full length 66kDa estrogen receptor alpha (ER ) stimulates target gene transcription through two activation functions (AF), AF-1 in the N-terminal domain and AF-2 in the ligand binding domain. Another physiologically expressed 46kDa ER isoform lacks the N-terminal A/B domains and is consequently devoid of AF-1. The aim of the present work was to directly evaluate the involvement of ER AF-1 and ER AF-2 in two major vasculoprotective effects of E2, i.e the reendothelialization process and the development of atherosclerosis. To this end, we developed mouse model, the first lacking the ER A/B domains that we named ER AF-1 0 and the second in which amino acid 543 to 548 of ERα were deleted, that we named ER AF-2 0 
Whereas ER AF-1 is dispensable, ER AF-2 is necessary for the E2 atheroprotective effect

Conclusion
Schematic representation of the wildtype ERα gene (Esr1) and the targeted AF1 0 and AF2 0 function.
Generation of ER AF-1 0 and
AF-2 0 mice ER AF-1 and AF-2 are dispensable for the effect of E2 on carotid endothelial healing
B.
In these ERαAF-10 mice, both basal endothelial NO production and reendothelialization process were increased by E2 administration in a similar extent than in control mice. Furthermore, exogenous E2 similarly decreased fatty streak deposits at the aortic root from both ovariectomized 18 week-old ERαAF-1+/+ LDL-r-/-(Low Density Lipoprotein receptor) and ERαAF-10 LDL-r-/-mice fed with a hypercholesterolemic diet. In addition, quantification of lesion size on en face preparations of the aortic tree of 8 month-old ovariectomized or intact female mice revealed that ERα AF-1 is dispensable for the atheroprotective action of endogenous estrogens. We conclude that ERα AF-1 is not required for three major vasculoprotective actions of E2, whereas it is necessary for the effects of E2 on its reproductive targets. Thus, Selective Estrogen Receptor Modulators stimulating ERα with minimal activation of ERα AF-1 could retain beneficial vascular actions, while minimizing the sexual effects.
ER AF-1 and AF-2 are necessary for the E2 uterotrophic action B. Uterine weight from mice treated or not with E2 (80µg/kg/day). 
Placebo E2
Exogenous E2 prevents fatty streak deposit in 18-week-old ERαAF-1 0 and ERαAF-2 0 mice Four-week-old ovariectomized mice were given either placebo or E2 (80µg/kg/day during 12 weeks) and switched to atherogenic diet from the age of 6 to 18 weeks. Representative micrographs of Oil red-O lipid stained cryosections of the aortic sinus. Scale bars correspond to 200 µm and quantification (mean ± SEM) of lesion area at the aortic sinus from an average of 7 or 8 mice per group. 
E2 control
